NZ207917A - Pharmaceutical compositions containing co-dergocrine and a calcium antagonist - Google Patents

Pharmaceutical compositions containing co-dergocrine and a calcium antagonist

Info

Publication number
NZ207917A
NZ207917A NZ207917A NZ20791784A NZ207917A NZ 207917 A NZ207917 A NZ 207917A NZ 207917 A NZ207917 A NZ 207917A NZ 20791784 A NZ20791784 A NZ 20791784A NZ 207917 A NZ207917 A NZ 207917A
Authority
NZ
New Zealand
Prior art keywords
preparation according
dergocrine
ratio
pharmaceutical
preparation
Prior art date
Application number
NZ207917A
Other languages
English (en)
Inventor
D Welzel
H Buhlmann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ207917A publication Critical patent/NZ207917A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ207917A 1983-04-22 1984-04-19 Pharmaceutical compositions containing co-dergocrine and a calcium antagonist NZ207917A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3314607 1983-04-22

Publications (1)

Publication Number Publication Date
NZ207917A true NZ207917A (en) 1988-05-30

Family

ID=6197070

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ207917A NZ207917A (en) 1983-04-22 1984-04-19 Pharmaceutical compositions containing co-dergocrine and a calcium antagonist

Country Status (27)

Country Link
US (2) US4617306A (enExample)
JP (1) JPS59205318A (enExample)
AT (1) AT393625B (enExample)
AU (1) AU571218B2 (enExample)
BE (1) BE899434A (enExample)
CA (1) CA1218932A (enExample)
CH (1) CH658992A5 (enExample)
CY (1) CY1499A (enExample)
DD (1) DD217712A5 (enExample)
DK (1) DK165965C (enExample)
FR (1) FR2544614B1 (enExample)
GB (1) GB2138678B (enExample)
GR (1) GR81973B (enExample)
HK (1) HK100289A (enExample)
HU (1) HU192050B (enExample)
IE (1) IE57468B1 (enExample)
IL (1) IL71601A (enExample)
IT (1) IT1199114B (enExample)
LU (1) LU85331A1 (enExample)
MY (1) MY100397A (enExample)
NL (1) NL188891C (enExample)
NZ (1) NZ207917A (enExample)
PH (1) PH20922A (enExample)
PT (1) PT78455B (enExample)
SE (1) SE465751B (enExample)
SG (1) SG53889G (enExample)
ZA (1) ZA842993B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159604B1 (en) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
EP1970052A2 (en) * 1999-02-09 2008-09-17 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
US6209563B1 (en) 2000-01-07 2001-04-03 Saturn Electronics & Engineering, Inc. Solenoid control valve
US6321767B1 (en) 2000-01-10 2001-11-27 Saturn Electronics & Engineering, Inc. High flow solenoid control valve
US6581634B2 (en) 2000-01-10 2003-06-24 Saturn Electronics & Engineering, Inc. Solenoid control valve with particle gettering magnet
US20090166274A1 (en) * 2007-05-24 2009-07-02 Eaton Corporation Engine valve with a combined engine oil filter and valve actuator solenoid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5468M (enExample) * 1966-06-24 1967-10-16
US3567828A (en) * 1967-08-17 1971-03-02 Sandoz Ltd Organic compounds
SE426782B (sv) * 1975-05-31 1983-02-14 Sandoz Ag Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter
JPS5487177A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Component positioning unit
WO1980001242A1 (fr) * 1978-12-21 1980-06-26 Sandoz Ag Preparations galeniques
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
GB2063670A (en) * 1979-11-28 1981-06-10 Sandoz Products Ltd Ergots and their use in treating minimal brain dysfunction

Also Published As

Publication number Publication date
IE840977L (en) 1984-10-22
GB2138678A (en) 1984-10-31
DD217712A5 (de) 1985-01-23
SE8402199D0 (sv) 1984-04-19
HK100289A (en) 1989-12-29
AU571218B2 (en) 1988-04-14
DK201884D0 (da) 1984-04-18
DK201884A (da) 1984-10-23
GR81973B (enExample) 1984-12-12
GB2138678B (en) 1986-11-05
PT78455A (en) 1984-05-01
CA1218932A (en) 1987-03-10
JPS59205318A (ja) 1984-11-20
IT1199114B (it) 1988-12-30
LU85331A1 (fr) 1984-11-28
FR2544614B1 (fr) 1987-08-21
PH20922A (en) 1987-06-05
SE465751B (sv) 1991-10-28
PT78455B (en) 1986-05-27
IE57468B1 (en) 1993-01-27
HU192050B (en) 1987-05-28
ZA842993B (en) 1985-11-27
NL188891C (nl) 1992-11-02
DK165965B (da) 1993-02-22
CY1499A (en) 1990-08-03
IL71601A (en) 1988-12-30
IT8448082A0 (it) 1984-04-20
ATA133784A (de) 1991-05-15
CH658992A5 (de) 1986-12-31
NL8401155A (nl) 1984-11-16
SG53889G (en) 1989-12-08
FR2544614A1 (fr) 1984-10-26
JPH0564124B2 (enExample) 1993-09-14
US4797404A (en) 1989-01-10
SE8402199L (sv) 1984-10-23
AU2712084A (en) 1984-10-25
IT8448082A1 (it) 1985-10-20
IL71601A0 (en) 1984-07-31
HUT37889A (en) 1986-03-28
DK165965C (da) 1993-07-26
US4617306A (en) 1986-10-14
GB8410363D0 (en) 1984-05-31
BE899434A (fr) 1984-10-16
MY100397A (en) 1990-09-17
AT393625B (de) 1991-11-25

Similar Documents

Publication Publication Date Title
JP4754068B2 (ja) δ−オピオイドレセプターに結合する４−［アリール（ピペリジン−４−イル）］アミノベンズアミド類
JP3097697B2 (ja) 光学的に純粋な（＋）ノルシサプリドを用いた嘔吐および中枢神経系障害の治療方法
WO2005070429A1 (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
CN87100563A (zh) 含n-杂环基-4-哌啶胺类的抗组胺组合物
EP1145714A1 (en) Drugs
NZ207917A (en) Pharmaceutical compositions containing co-dergocrine and a calcium antagonist
JPH05132430A (ja) 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法
US3760074A (en) Pharmaceutical compositions containing a 5-phenyl-7-bromo-1h-1,5-benzodiazepine-2,4-(3h,5h)-dione
JP2952425B2 (ja) トリフルオロメチルフェニルテトラヒドロピリジン誘導体を含む腸管運動障害の予防用および／または治療用医薬製剤
DE2601262A1 (de) 1-r-4-(omega-substituierte alkyl)-3, 3-diphenyl-2-pyrrolidinone und verfahren zu ihrer herstellung
SK286040B6 (sk) Farmaceutická kompozícia obsahujúca 1-(2-naft-2-yletyl)-4-(3- trifluórmetylfenyl)-1,2,3,6-tetrahydropyridín hydrochlorid a donepezil alebo takrín
JP2002504134A (ja) 疼痛を治療するためのドラフラジン類似体の使用
CN101778632B (zh) 综合失调症的治疗或预防药
JP2002527381A (ja) アレルギー性疾患を処置するための組成物および方法
SK11695A3 (en) Use of 3-benzoyl-3,7-diazobicyclo£3,3,1| nonane compounds as antiarhytmic effective medicament and method of its production
BRPI0717161A2 (pt) Agente para profilaxia ou tratamento de abuso e dependência de substância.
DE3413955A1 (de) Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten
JP2000273042A (ja) 医 薬
MXPA06008113A (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
JPH02160790A (ja) ジアンヒドロヘキシトールのアシル誘導体
JPS6019768A (ja) メチルレバロルフアニウム塩化合物およびその製造方法並びに薬剤
CY1702A (en) Pharmaceutical composition for use against hypertension and congestive heart failure
SK156698A3 (en) Use of substituted azaspirane in the treatment of asthma
MXPA98010024A (en) Treatment of the prur
DE8718021U1 (de) Kondensierte Bis-(3,4-dihydro-1-pyridiny1)methane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel